Randomized, double-blind, Phase 111, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (ARILVAXTMand YF-VAX) in healthy infants and children in Peru
Contribuinte(s) |
James W. Kazura |
---|---|
Data(s) |
01/01/2005
|
Identificador | |
Idioma(s) |
eng |
Publicador |
American Society of Tropical Medicine and Hygiene |
Palavras-Chave | #CX #320204 Immunogenetics #730101 Infectious diseases |
Tipo |
Journal Article |